Literature DB >> 30607435

Diagnostic performance of quantitative magnetic resonance imaging biomarkers for predicting portal hypertension in children and young adults with autoimmune liver disease.

Jonathan R Dillman1,2,3, Suraj D Serai4,5, Andrew T Trout4,6,7, Ruchi Singh6,8, Jean A Tkach4, Amy E Taylor6,8, Burns C Blaxall9, Lin Fei10, Alexander G Miethke6,8.   

Abstract

BACKGROUND: Primary sclerosing cholangitis, autoimmune hepatitis and autoimmune sclerosing cholangitis are forms of chronic, progressive autoimmune liver disease (AILD) that can affect the pediatric population.
OBJECTIVE: To determine whether quantitative MRI- and laboratory-based biomarkers are associated with conventional imaging findings of portal hypertension (radiologic portal hypertension) in children and young adults with AILD.
MATERIALS AND METHODS: Forty-four patients with AILD enrolled in an institutional registry underwent a research abdominal MRI examination at 1.5 tesla (T). Five quantitative MRI techniques were performed: liver MR elastography, spleen MR elastography, liver iron-corrected T1 mapping, liver T2 mapping, and liver diffusion-weighted imaging (DWI, quantified as apparent diffusion coefficients). Two anatomical sequences were used to document splenomegaly, varices and ascites. We calculated aspartate aminotransferase (AST)-to-platelet ratio index (APRI) and fibrosis-4 (FIB-4) scores - laboratory-based biomarkers of liver fibrosis. We used receiver operating characteristic (ROC) curve analyses to establish the diagnostic performance of quantitative MRI and laboratory biomarkers for indicating the presence of radiologic portal hypertension.
RESULTS: Twenty-three (52%) patients were male; mean age was 15.2±4.0 years. Thirteen (30%) patients had radiologic portal hypertension. Liver and spleen stiffness demonstrated the greatest diagnostic performance for indicating the presence of portal hypertension (area-under-the-ROC-curve [AUROC]=0.98 and 0.96, respectively). The APRI and FIB-4 scores also demonstrated good diagnostic performance (AUROC=0.87 and 0.88, respectively).
CONCLUSION: MRI-derived measures of liver and spleen stiffness as well as laboratory-based APRI and FIB-4 scores are highly associated with imaging findings of portal hypertension in children and young adults with AILD and thus might be useful for predicting portal hypertension impending onset and directing personalized patient management.

Entities:  

Keywords:  Autoimmune liver disease; Children; Liver; Magnetic resonance elastography; Magnetic resonance imaging; Multiparametric; Portal hypertension

Mesh:

Substances:

Year:  2019        PMID: 30607435     DOI: 10.1007/s00247-018-4319-1

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  22 in total

1.  Assessment of liver fibrosis and cirrhosis by aspartate aminotransferase-to-platelet ratio index in children with biliary atresia.

Authors:  Sang Yong Kim; Jae Yeon Seok; Seok Joo Han; Hong Koh
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-08       Impact factor: 2.839

2.  Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease.

Authors:  Stavra A Xanthakos; Daniel J Podberesky; Suraj D Serai; Lili Miles; Eileen C King; William F Balistreri; Rohit Kohli
Journal:  J Pediatr       Date:  2013-09-21       Impact factor: 4.406

Review 3.  Magnetic resonance elastography of liver and spleen: Methods and applications.

Authors:  Philippe Garteiser; Sabrina Doblas; Bernard E Van Beers
Journal:  NMR Biomed       Date:  2018-01-25       Impact factor: 4.044

4.  Portal hypertension correlates with splenic stiffness as measured with MR elastography.

Authors:  Geir I Nedredal; Meng Yin; Travis McKenzie; Joseph Lillegard; Jennifer Luebke-Wheeler; Jayant Talwalkar; Richard Ehman; Scott L Nyberg
Journal:  J Magn Reson Imaging       Date:  2011-05-23       Impact factor: 4.813

Review 5.  Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.

Authors:  Zhong-Hua Lin; Yong-Ning Xin; Quan-Jiang Dong; Qing Wang; Xiang-Jun Jiang; Shu-Hui Zhan; Ying Sun; Shi-Ying Xuan
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

6.  Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations.

Authors:  Meng Yin; Kevin J Glaser; Jayant A Talwalkar; Jun Chen; Armando Manduca; Richard L Ehman
Journal:  Radiology       Date:  2015-07-08       Impact factor: 11.105

Review 7.  Reversibility of liver fibrosis.

Authors:  Mengxi Sun; Tatiana Kisseleva
Journal:  Clin Res Hepatol Gastroenterol       Date:  2015-07-20       Impact factor: 2.947

8.  The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.

Authors:  Mark R Deneau; Wael El-Matary; Pamela L Valentino; Reham Abdou; Khaled Alqoaer; Mansi Amin; Achiya Z Amir; Marcus Auth; Fateh Bazerbachi; Annemarie Broderick; Albert Chan; Jillian Cotter; Sylvia Doan; Mounif El-Youssef; Federica Ferrari; Katryn N Furuya; Madeleine Gottrand; Frederic Gottrand; Nitika Gupta; Matjaz Homan; Binita M Kamath; Kyung Mo Kim; Kaija-Leena Kolho; Anastasia Konidari; Bart Koot; Raffaele Iorio; Oren Ledder; Cara Mack; Mercedes Martinez; Tamir Miloh; Parvathi Mohan; Niamh O'Cathain; Alexandra Papadopoulou; Amanda Ricciuto; Lawrence Saubermann; Pushpa Sathya; Eyal Shteyer; Vratislav Smolka; Atushi Tanaka; Raghu Varier; Veena Venkat; Bernadette Vitola; Miriam B Vos; Marek Woynarowski; Jason Yap; M Kyle Jensen
Journal:  Hepatology       Date:  2017-06-26       Impact factor: 17.425

9.  Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis.

Authors:  Maxime Ronot; Simon Lambert; Laure Elkrief; Sabrina Doblas; Pierre-Emmanuel Rautou; Laurent Castera; Valérie Vilgrain; Ralph Sinkus; Bernard E Van Beers; Philippe Garteiser
Journal:  Eur Radiol       Date:  2014-03-14       Impact factor: 5.315

10.  Diagnostic Performance of MR Elastography for Liver Fibrosis in Children and Young Adults with a Spectrum of Liver Diseases.

Authors:  Andrew T Trout; Rachel M Sheridan; Suraj D Serai; Stavra A Xanthakos; Weizhe Su; Bin Zhang; Daniel B Wallihan
Journal:  Radiology       Date:  2018-02-22       Impact factor: 11.105

View more
  8 in total

Review 1.  Noninvasive imaging assessment of portal hypertension.

Authors:  Paul Kennedy; Octavia Bane; Stefanie J Hectors; Aaron Fischman; Thomas Schiano; Sara Lewis; Bachir Taouli
Journal:  Abdom Radiol (NY)       Date:  2020-09-14

2.  MR elastography, T1 and T2 relaxometry of liver: role in noninvasive assessment of liver function and portal hypertension.

Authors:  David H Hoffman; Abimbola Ayoola; Dominik Nickel; Fei Han; Hersh Chandarana; James Babb; Krishna Prasad Shanbhogue
Journal:  Abdom Radiol (NY)       Date:  2020-09

Review 3.  MR elastography in primary sclerosing cholangitis: a pictorial review.

Authors:  Christopher L Welle; Patrick J Navin; Michael C Olson; Safa Hoodeshenas; Michael S Torbenson; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2022-05-14

Review 4.  Basics of magnetic resonance imaging and quantitative parameters T1, T2, T2*, T1rho and diffusion-weighted imaging.

Authors:  Suraj D Serai
Journal:  Pediatr Radiol       Date:  2021-04-15

Review 5.  Magnetic resonance elastography of the liver: everything you need to know to get started.

Authors:  Kay M Pepin; Christopher L Welle; Flavius F Guglielmo; Jonathan R Dillman; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2021-11-01

6.  Associations between MRI T1 mapping, liver stiffness, quantitative MRCP, and laboratory biomarkers in children and young adults with autoimmune liver disease.

Authors:  Neeraja Mahalingam; Andrew T Trout; Deep B Gandhi; Rashmi D Sahay; Ruchi Singh; Alexander G Miethke; Jonathan R Dillman
Journal:  Abdom Radiol (NY)       Date:  2021-12-21

7.  Validation and feasibility of liver T1 mapping using free breathing MOLLI sequence in children and young adults.

Authors:  Yeon Jin Cho; Woo Sun Kim; Young Hun Choi; Seul Bi Lee; SeungHyun Lee; Jung-Eun Cheon; MunYoung Paek; SeungTae Woo
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

Review 8.  Multiparametric MR mapping in clinical decision-making for diffuse liver disease.

Authors:  Helena B Thomaides-Brears; Rita Lepe; Rajarshi Banerjee; Carlos Duncker
Journal:  Abdom Radiol (NY)       Date:  2020-08-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.